Pages that link to "Q42992789"
Jump to navigation
Jump to search
The following pages link to Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood (Q42992789):
Displaying 24 items.
- Characterization of differential antibody production against hepatitis C virus in different HCV infection status (Q27469004) (← links)
- Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection (Q27488889) (← links)
- Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody (Q27488912) (← links)
- Structural basis for broad neutralization of hepatitis C virus quasispecies (Q34064882) (← links)
- A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV) (Q34295420) (← links)
- Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review (Q34637206) (← links)
- HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women (Q35056682) (← links)
- Development of a Multiplex Bead-Based Assay for Detection of Hepatitis C Virus (Q35066209) (← links)
- Acute hepatitis C in a chronically HIV-infected patient: evolution of different viral genomic regions (Q36190673) (← links)
- Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection (Q36517794) (← links)
- A novel double antibody sandwich-lateral flow immunoassay for the rapid and simple detection of hepatitis C virus (Q36613617) (← links)
- Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimation (Q41488562) (← links)
- Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus (Q42988195) (← links)
- Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area. (Q42992220) (← links)
- Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C. (Q42996975) (← links)
- Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems (Q42998799) (← links)
- Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus. (Q43038680) (← links)
- Virus-specific antibody titres in different phases of hepatitis C virus infection (Q43040987) (← links)
- Decreased anti‐hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: A prospective study (Q43041377) (← links)
- Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000. (Q43795768) (← links)
- Rubella virus nonstructural protein 2 is a minor immunogen (Q44851491) (← links)
- Seroprevalence of hepatitis C virus (HCV) infection among blood donors: a hospital-based study (Q45738638) (← links)
- Natural course of acute hepatitis C: a long-term prospective study (Q47912531) (← links)
- Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C. (Q52060036) (← links)